Home › Trial NCT00171873
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
- Trial IDNCT00171873
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorCarmen Schade-Brittinger
- Enrollment85
- Start date2001-09
- ConditionsNeuroendocrine Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.